High-Dose vitamin c infusions tested in fight against aggressive brain cancer
NCT ID NCT04900792
Summary
This early-stage trial is testing if adding high-dose vitamin C (given by IV) and an iron-based drug called ferumoxytol to the standard treatment for glioblastoma brain tumors is safe and helpful. The study involves about 17 adults who have just been diagnosed. The main goal is to find the safest dose of the iron drug to use in future research, while also checking if the combination might help control the tumor and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiation Oncology at University of Iowa
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.